S'abonner

The interaction of exercise ability and body mass index upon long-term outcomes among patients undergoing stress-rest perfusion single-photon emission computed tomography imaging - 29/06/13

Doi : 10.1016/j.ahj.2013.03.027 
Seth Uretsky, MD , Azhar Supariwala, MD, Srinivasa Gurram, MD, Sri Lakshmi Kala Bonda, MD, Naganath Thota, MD, Prema Bezwada, MD, Seema Manchireddy, MD, Subu Nair, MD, Randy Cohen, MD, Alan Rozanski, MD
 Division of Cardiology, Department of Medicine, St Luke's–Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY 

Reprint requests: Seth Uretsky, MD, Division of Cardiology, Department of Medicine, St Luke's–Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, 1111 Amsterdam Ave, Cardiology 3rd Floor, New York, NY 10025.

Résumé

Background

The obesity paradox has been reported in several populations of patients with cardiovascular disease. Recent data have shown that physical fitness may attenuate the obesity paradox. Patients who undergo pharmacologic stress testing are known to have a higher risk of mortality than those who can exercise. The purpose of this study is to determine the interaction of obesity and exercise ability on survival among patients with a normal stress-rest single-photon emission computed tomography (SPECT).

Methods

A total of 5,203 (60 ± 13 years, male 37%) patients without a history of heart disease and a normal stress-rest SPECT between the years 1995 and 2010 were included in this analysis. Body mass index categories were defined according to the World Health Organization classification: normal weight, 18.5 to 24.9 kg/m2; overweight, 25 to 29.9 kg/m2; and obese, ≥30 kg/m2. Patients were divided into 3 groups based on their ability to exercise: those who reached ≥6 METs on exercise, those who attained a level of <6 METs, and those who required pharmacologic stress. Patients in each of these fitness groups were further divided into 3 subgroups based on their body mass index.

Results

There were 939 (18%) deaths during a mean follow-up of 8.1 ± 4.1 years, for an overall event rate of 2.3%/y. Both exercise to ≥6 METs and being obese were associated with lower mortality. Adjusted multivariate analysis using the obese high-fit patients as the reference showed a wide heterogeneity in annualized mortality rates according to exercise and weight status, with annualized event rates which varied from 0.6%/y in the obese subjects who were physically fit to 5.3%/y among healthy subjects who underwent pharmacologic stress testing (P < .001).

Conclusions

Stress mode and body weight impacted long-term survival in patients with a normal stress SPECT. The benefit of being physically fit was evident in all weight groups, as was the adverse effect of being unable to exercise. However, with regard to body weight, there was a paradoxical survival advantage for those patients who were overweight and obese, regardless of their exercise ability.

Le texte complet de cet article est disponible en PDF.

Plan


© 2013  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 166 - N° 1

P. 127-133 - juillet 2013 Retour au numéro
Article précédent Article précédent
  • Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction : Insights from the EXAMINATION trial
  • Josep Gomez-Lara, Salvatore Brugaletta, Joan-Antoni Gomez-Hospital, Jose Luis Ferreiro, Gerard Roura, Rafael Romaguera, Victoria Martin-Yuste, Monica Masotti, Andrés Iñiguez, Antonio Serra, Rosana Hernandez-Antolin, Vicente Mainar, Marco Valgimigli, Maurizio Tespili, Pieter den Heijer, Armando Bethencourt, Nicolás Vazquez, Patrick Serruys, Manel Sabate, Angel Cequier
| Article suivant Article suivant
  • Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory
  • Barry Sharaf, Todd Wood, Leslee Shaw, B. Delia Johnson, Sheryl Kelsey, R. David Anderson, Carl J. Pepine, C. Noel Bairey Merz

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.